Replies to post #2821 on The Rising Influence of Rising Affluence

[DewDiligence]

PFE/Hisun dissolve branded-generics JV in China:

https://www.bloomberg.com/news/articles/2017-11-10/pfizer-sells-stake-in-china-s-hisun-ending-drugs-joint-venture

I don’t have an explanation for why this JV didn’t work out. ABT makes very good money from selling branded generics in emerging markets, so I don’t see why PFE couldn’t do it.